Literature DB >> 2702712

Supplemental administration of 1 alpha-hydroxyvitamin D3 inhibits promotion by intrarectal instillation of lithocholic acid in N-methyl-N-nitrosourea-induced colonic tumorigenesis in rats.

A Kawaura1, N Tanida, K Sawada, M Oda, T Shimoyama.   

Abstract

The effect of 1 alpha-hydroxyvitamin D3 [1 alpha(OH)D3] on promotion by intrarectal instillation of lithocholic acid (LC) in N-methyl-N-nitrosourea (MNU)-induced colonic tumorigenesis was studied in a rodent model. Ninety-two female F344 rats received intrarectal injection of 2.5 mg of MNU twice in one week followed by 1 mg of LC or its vehicle alone three times weekly for 48 weeks. Those which received LC were given a concomitant intragastric administration of 0.04 micrograms of 1 alpha(OH)D3 or its vehicle alone three times weekly. In the group receiving MNU alone (n = 30) five rats bore colonic tumors; in the MNU + LC group (n = 32) 15 and in the MNU + LC + 1 alpha(OH)D3 group (n = 30) six rats bore colonic tumors (MNU + LC versus MNU + LC + 1 alpha(OH)D3 group, P less than 0.05). These results indicated that promotion of MNU-induced colonic tumorigenesis by LC was suppressed by supplemental administration of 1 alpha(OH)D3.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2702712     DOI: 10.1093/carcin/10.4.647

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  11 in total

1.  Update of preclinical and human studies of calcium and colon cancer prevention.

Authors:  Martin Lipkin
Journal:  World J Gastroenterol       Date:  1999-12       Impact factor: 5.742

2.  Regulation of VDR Expression in Apc-Mutant Mice, Human Colon Cancers and Adenomas.

Authors:  Charles Giardina; Masako Nakanishi; Awaad Khan; Anton Kuratnik; Wanli Xu; Bruce Brenner; Daniel W Rosenberg
Journal:  Cancer Prev Res (Phila)       Date:  2015-04-14

3.  Calcitriol enhancement of TPA-induced tumorigenic transformation is mediated through vitamin D receptor-dependent and -independent pathways.

Authors:  P L Chang; T F Lee; K Garretson; C W Prince
Journal:  Clin Exp Metastasis       Date:  1997-11       Impact factor: 5.150

Review 4.  Vitamin D resistance and colon cancer prevention.

Authors:  Charles Giardina; James P Madigan; Cassandra A Godman Tierney; Bruce M Brenner; Daniel W Rosenberg
Journal:  Carcinogenesis       Date:  2011-12-16       Impact factor: 4.944

Review 5.  Effects of supplemental vitamin D and calcium on normal colon tissue and circulating biomarkers of risk for colorectal neoplasms.

Authors:  Roberd M Bostick
Journal:  J Steroid Biochem Mol Biol       Date:  2015-01-15       Impact factor: 4.292

6.  Inactivation of the vitamin D receptor in APC(min/+) mice reveals a critical role for the vitamin D receptor in intestinal tumor growth.

Authors:  Wei Zheng; Kari E Wong; Zhongyi Zhang; Urzsula Dougherty; Reba Mustafi; Juan Kong; Dilip K Deb; Huachuan Zheng; Marc Bissonnette; Yan Chun Li
Journal:  Int J Cancer       Date:  2011-04-20       Impact factor: 7.396

7.  Role of bile acid secretion in human colorectal cancer.

Authors:  Meinrad Peterlik
Journal:  Wien Med Wochenschr       Date:  2008

8.  Effects of vitamin D and calcium supplementation on markers of apoptosis in normal colon mucosa: a randomized, double-blind, placebo-controlled clinical trial.

Authors:  Veronika Fedirko; Roberd M Bostick; W Dana Flanders; Qi Long; Aasma Shaukat; Robin E Rutherford; Carrie R Daniel; Vaunita Cohen; Chiranjeev Dash
Journal:  Cancer Prev Res (Phila)       Date:  2009-03-03

9.  Inhibition of development of N,N'-dimethylhydrazine-induced rat colonic aberrant crypt foci by pre, post and simultaneous treatments with 24R,25-dihydroxyvitamin D3.

Authors:  E I Salim; H Wanibuchi; T Taniyama; Y Yano; K Morimura; S Yamamoto; S Otani; Y Nishizawa; H Morii; S Fukushima
Journal:  Jpn J Cancer Res       Date:  1997-11

10.  Effects of supplemental vitamin D and calcium on markers of proliferation, differentiation, and apoptosis in the normal colorectal mucosa of colorectal adenoma patients.

Authors:  Yasheen Gao; Caroline Y Um; Veronika Fedirko; Robin E Rutherford; March E Seabrook; Elizabeth L Barry; John A Baron; Roberd M Bostick
Journal:  PLoS One       Date:  2018-12-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.